20/12/2014 07:15:50 Free Membership Login

Herborium Announces Continuing Progress In Key Strategic Initiatives

Date : 05/04/2012 @ 8:15AM
Source : PR Newswire (US)
Stock : Herborium Group, Inc. (PC) (HBRM)
Quote : 0.00059  0.00009 (18.00%) @ 4:02PM
Herborium Group, Inc. share price Chart

Herborium Announces Continuing Progress In Key Strategic Initiatives

Herborium Group, Inc. (USOTC:HBRM)
Historical Stock Chart

3 Years : From Dec 2011 to Dec 2014

Click Here for more Herborium Group, Inc. Charts.

TEANECK, N.J., May 4, 2012 /PRNewswire/ -- Herborium Group, Inc., (PINKS. HBRM) www.herborium.com, a Botanical Therapeutics® company, reports today continuing progress with its key strategic initiatives.

The company is progressing through the negotiating phase with China Health Resource Inc. regarding a potential acquisition. Both, Herborium Group and China Resource continue to work diligently towards a successful transaction.      

Herborium's partnership with KAMASUTRA (USA), LLC  to commercialize their unique vodka product containing Herborium's proprietary herbal formula  derived from the Company's sexual health formulations, has moved into the introductory marketing phase with the digital marketing plan to be initiated in June 2012.  Market share for vodka in the US is $4.8 Billion in annual sales with both on premise and home consumption on the rise.  KAMASUTRA (USA) LLC is the US partner of the German Bismarck Premium Brands GmbH  www.bismarck.de  and http://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html.

The market for pharmaceutical sexual health products is over $3.2 billion worldwide. The market for natural sexual health products is estimated to be over $1.5 billion, and growing.

Dr. Agnes P. Olszewski, CEO of Herborium, recently completed the National Publicity Summit in New York City (April 25-29, 2012). The Company is looking forward to multiple media exposure opportunities resulting from this Summit  that shall greatly elevate  Herborium's  public awareness.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company markets its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com

SOURCE Herborium Group, Inc.

Copyright 2012 PR Newswire



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us 141220 07:15